IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 252 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $191,348 | -36.3% | 19,870 | -29.6% | 0.04% | -53.4% |
| Q2 2023 | $300,261 | +6.7% | 28,220 | +5.5% | 0.09% | -2.2% |
| Q1 2023 | $281,410 | -14.3% | 26,750 | +1.0% | 0.09% | -17.4% |
| Q4 2022 | $328,298 | +35.7% | 26,497 | +13.3% | 0.11% | -8.4% |
| Q3 2022 | $242,000 | +8.0% | 23,387 | +20.5% | 0.12% | -14.4% |
| Q2 2022 | $224,000 | +23.1% | 19,409 | +33.8% | 0.14% | +52.7% |
| Q1 2022 | $182,000 | +15.2% | 14,504 | +7.4% | 0.09% | +24.7% |
| Q4 2021 | $158,000 | +364.7% | 13,503 | +422.6% | 0.07% | +231.8% |
| Q3 2021 | $34,000 | -50.0% | 2,584 | -51.4% | 0.02% | -48.8% |
| Q2 2021 | $68,000 | +223.8% | 5,316 | +183.2% | 0.04% | +26.5% |
| Q1 2021 | $21,000 | – | 1,877 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $188,977,000 | 19.02% |
| 13D Management LLC | 600,431 | $6,923,000 | 3.06% |
| BRIDGER MANAGEMENT, LLC | 956,014 | $11,023,000 | 2.48% |
| Brown Capital Management | 11,641,935 | $134,232,000 | 1.80% |
| Price Jennifer C. | 520,000 | $5,996,000 | 1.02% |
| Monarch Partners Asset Management LLC | 272,425 | $3,141,000 | 0.88% |
| ALPHASIMPLEX GROUP, LLC | 10,510 | $121,000 | 0.86% |
| Intrinsic Value Partners, LLC | 54,105 | $624,000 | 0.80% |
| CLARK ESTATES INC/NY | 355,000 | $4,093,000 | 0.71% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 692 | $60,000,000 | 0.63% |